Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults
Clinical trial NCT00696891 · COMPLETED
Trial details
- NCT number
- NCT00696891
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-06-01
- Primary completion
- 1999-05-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.